We are live on ! Find out more
CVSC

C.V. Starr & Co Portfolio holdings

AUM $192M
1-Year Est. Return 35.69%
This Fund
S&P 500
This Quarter Est. Return
+65.17%
1 Year Est. Return
+35.69%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$71.4M
AUM Growth
+$44.3M
Cap. Flow
+$19.9M
Cap. Flow %
27.85%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
CELU icon
Celularity
CELU
+$19.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 93.16%
2 Consumer Discretionary 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CELU icon
1
Celularity
CELU
$21.7M
$66.5M 93.16%
764,069
+332,034
+77% +$19.9M
AMZN icon
2
Amazon
AMZN
$2.5T
$4.89M 6.84%
30,000

Similar funds

C.V. Starr & Co's Q1 2022 Portfolio in Review

As of Q1 2022, C.V. Starr & Co held 2 positions worth $71.4M, up 163% from $27.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

C.V. Starr & Co deployed $19.9M of net new capital in Q1 2022, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 82% a quarter earlier, followed by Consumer Discretionary.

  • C.V. Starr & Co added most to Celularity in Q1 2022, an estimated $19.9M increase.
  • C.V. Starr & Co's ten largest holdings make up 100% of its $71.4M portfolio in Q1 2022.
  • C.V. Starr & Co opened 0 new positions and closed 0 in Q1 2022.
  • C.V. Starr & Co's portfolio value rose 163% quarter-over-quarter to $71.4M.

Based on C.V. Starr & Co's 13F filing for Q1 2022, filed 11 May 2022.